This kit uses RT-PCR for in vitro detection of MERS-CoV in nasopharyngeal and/or oropharyngeal swab samples. Test results may serve as a reference for clincial evaluation fo MERS-CoV infection. Based on high-efficiency enymatic processing technology, sample processing and purification are simultaneously completed in on etube to release and stabilize the pathogen nucleic acid. The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
Only one step for nucleic acid processing, reducing operations to direct PCR sample processing and amplification. Turnaround time is less than 35 minutes.